SEC Form 4 · accession 0001193125-26-299665
Vor Biopharma Inc. · VOR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Zaccardelli
Director
Period of report
Jul 7, 2026
Accepted (ET)
Jul 9, 2026 · 4:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001817229
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $20.10 | Jul 7, 2026 | A | 42,658 | A | — | Jul 6, 2036 | Common Stock | 42,658 | 42,658 | D |
Explanation of responses
- F1The shares shall vest and become exercisable in a series of 36 successive equal monthly installments beginning on August 7, 2026, in each case subject to the Reporting Person's continued service as of each such date.